Maria Oliva-Hemker, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Takeda Pharmaceuticals
    Topic:
    vedolizumab trial
    Date added:
    04/01/2025
    Date updated:
    04/01/2025
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Predict Immune Inc
    Topic:
    IBD trial
    Date added:
    04/01/2025
    Date updated:
    04/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Pfizer
    Topic:
    IBD transition of care
    Date added:
    04/01/2025
    Date updated:
    04/01/2025
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Janssen Research & Development
    Topic:
    Guselkumab advisory board
    Date added:
    04/01/2025
    Date updated:
    04/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Prizer
    Topic:
    advisory board
    Date added:
    04/01/2025
    Date updated:
    04/01/2025
Return to Ninth Pediatric Inflammatory Bowel Disease Research Days (PIBDRD) Meeting